Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-096205
Filing Date
2024-11-12
Accepted
2024-11-12 07:24:54
Documents
89
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0219860-10q_avalon.htm   iXBRL 10-Q 1844173
2 CERTIFICATION ea021986001ex31-1_avalon.htm EX-31.1 13015
3 CERTIFICATION ea021986001ex31-2_avalon.htm EX-31.2 13204
4 CERTIFICATION ea021986001ex32-1_avalon.htm EX-32.1 5232
5 CERTIFICATION ea021986001ex32-2_avalon.htm EX-32.2 5200
  Complete submission text file 0001213900-24-096205.txt   9145263

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE avco-20240930.xsd EX-101.SCH 78449
7 XBRL CALCULATION FILE avco-20240930_cal.xml EX-101.CAL 53235
8 XBRL DEFINITION FILE avco-20240930_def.xml EX-101.DEF 421844
9 XBRL LABEL FILE avco-20240930_lab.xml EX-101.LAB 714427
10 XBRL PRESENTATION FILE avco-20240930_pre.xml EX-101.PRE 428726
92 EXTRACTED XBRL INSTANCE DOCUMENT ea0219860-10q_avalon_htm.xml XML 1074285
Mailing Address 4400 ROUTE 9 SUITE 3100 FREEHOLD NJ 07728
Business Address 4400 ROUTE 9 SUITE 3100 FREEHOLD NJ 07728 732-780-4400
Avalon GloboCare Corp. (Filer) CIK: 0001630212 (see all company filings)

EIN.: 471685128 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38728 | Film No.: 241443279
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)